Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

NCT00028756 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

285

Enrollment

NETWORK

Sponsor class

Conditions

Stage III Bladder Cancer
Stage IV Bladder Cancer
Transitional Cell Carcinoma of the Bladder

Interventions

DRUG: doxorubicin hydrochloride
DRUG: gemcitabine hydrochloride
DRUG: vinblastine sulfate
DRUG: methotrexate
DRUG: cisplatin
BIOLOGICAL: filgrastim

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]